Work

Ruxolitinib for the management of myelofibrosis: Results of an international physician survey

Year: 2017

Type: article

Study design: Observational Study

Source: Leukemia Research

DOI: 10.1016/j.leukres.2017.08.002

Authors: Martin H. Ellis, Maya Koren-Michowitz, Noa Lavi, Alessandro M Vannucchi, Ruben Mesa, Claire N Harrison

Institutions: Tel Aviv University, Meir Medical Center, Assaf Harofeh Medical Center, Technion – Israel Institute of Technology, Rambam Health Care Campus, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Mayo Clinic in Arizona, National Health Service, Guy's and St Thomas' NHS Foundation Trust

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Mays Cancer Center at UT Health SA

OpenAlex ID: W2742790272

FWCI: 0.77

Cites: 13

Cited by: 9

Related to: 10